• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种新型口服化学性霍乱双价疫苗的生化及免疫化学特性以及该制剂在志愿者身上的试验结果]

[Biochemical and immunochemical characteristics of a new oral, chemical cholera bivalent vaccine and results of a trial of the preparation on volunteers].

作者信息

Dzhaparidze M N, Nikitina G P, Ivanov N R, Rystsova E A, Udalova I B

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 1982(11):29-33.

PMID:6760628
Abstract

Oral cholera vaccine contains 45% of O-antigen (serovars Ogawa and Inaba in equal parts) and at least 9 serologically active proteins; of these, toxoid (about 60% of the total amount of protein) and 5 enzymes have been identified: neuraminidase, proteinase, ribonuclease, phospholipase and ATPase. The safety, absence of reactogenicity and definite immunological effectiveness of the preparation in the primary immunization of volunteers have been shown.

摘要

口服霍乱疫苗含有45%的O抗原(小川型和稻叶型血清型各占一半)以及至少9种具有血清学活性的蛋白质;其中,已鉴定出类毒素(约占蛋白质总量的60%)和5种酶:神经氨酸酶、蛋白酶、核糖核酸酶、磷脂酶和ATP酶。该制剂在志愿者的初次免疫中已显示出安全性、无反应原性以及明确的免疫效力。

相似文献

1
[Biochemical and immunochemical characteristics of a new oral, chemical cholera bivalent vaccine and results of a trial of the preparation on volunteers].[一种新型口服化学性霍乱双价疫苗的生化及免疫化学特性以及该制剂在志愿者身上的试验结果]
Zh Mikrobiol Epidemiol Immunobiol. 1982(11):29-33.
2
[The determination of the optimal inoculation dose of an oral cholera chemical bivalent vaccine in a controlled experiment].[在一项对照实验中确定口服霍乱化学二价疫苗的最佳接种剂量]
Zh Mikrobiol Epidemiol Immunobiol. 1990 Dec(12):55-62.
3
[Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].[富含小川型O抗原的霍乱毒素-类毒素化学性霍乱疫苗]
Zh Mikrobiol Epidemiol Immunobiol. 1984 Apr(4):70-4.
4
[The determination of the optimal inoculation dose of an oral cholera bivalent chemical vaccine in a controlled trial of the vaccination of children and adolescents].[在儿童和青少年霍乱双价化学疫苗接种对照试验中确定最佳接种剂量]
Zh Mikrobiol Epidemiol Immunobiol. 1993 Sep-Oct(5):55-60.
5
[The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].[基于对照试验结果的新型霍乱双价化学疫苗的反应原性和免疫活性特征]
Zh Mikrobiol Epidemiol Immunobiol. 1991 Jul(7):55-8.
6
[Oral chemical vaccine made from a toxigenic strain of V. cholerae, Ogawa serovar (an experimental study)].[由霍乱弧菌小川血清型产毒株制成的口服化学疫苗(一项实验研究)]
Zh Mikrobiol Epidemiol Immunobiol. 1979 Oct(10):62-8.
7
[Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination].[口服霍乱化学疫苗在人体再接种有限对照试验中的反应原性和免疫效果]
Zh Mikrobiol Epidemiol Immunobiol. 1978(12):87-92.
8
Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.构建同时表达 Inaba 和 Ogawa 血清型抗原的新型霍乱弧菌疫苗株。
Vaccine. 2011 Oct 6;29(43):7505-13. doi: 10.1016/j.vaccine.2011.06.121. Epub 2011 Jul 30.
9
A review of the current status of enteric vaccines.肠道疫苗现状综述
P N G Med J. 1995 Dec;38(4):325-31.
10
Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial.双价口服霍乱疫苗在多米尼加共和国 1 岁及以上参与者中的应用:一项 III 期、单臂、安全性和免疫原性试验。
Hum Vaccin Immunother. 2018 Jun 3;14(6):1403-1411. doi: 10.1080/21645515.2018.1430540. Epub 2018 Feb 22.